Markets:

Overview

News

Currencies

International

Treasuries

Pulse Biosciences, Inc - Common Stock (NQ:PLSE)

49.38 -5.82 (-10.54%)

Streaming Delayed Price Updated: 3:52 PM EDT, Sep 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Pulse Biosciences, Inc - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

12 Health Care Stocks Moving In Friday's Intraday Session ↗

March 31, 2023

Via Benzinga

Pulse Biosciences Reports Fourth Quarter & Full Year 2022 Financial Results

March 30, 2023

From Pulse Biosciences, Inc.

Via Business Wire

Earnings Scheduled For March 30, 2023 ↗

March 30, 2023

Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is estimated to report quarterly loss at $0.12 per share on revenue of $10.80 million.

Via Benzinga

A Preview Of Pulse Biosciences's Earnings ↗

March 29, 2023

Via Benzinga

Pulse Biosciences Lead Therapeutic System Scores FDA Approval For Sebaceous Hyperplasia ↗

September 26, 2022

Via Benzinga

Pulse Biosciences Shifts Core Technology Focus, Reduces Dermatologic Footprint ↗

September 21, 2022

Via Benzinga

Latest Executive Changes In Marijuana Industry, New Appointments & Resignations ↗

March 13, 2023

As the Benzinga Cannabis Capital Conference returns to Miami (April 11-12), gathering top CEOs, investors and leaders in the mari

Via Benzinga

Pulse Biosciences Schedules Fourth Quarter & Full Year 2022 Financial Results Conference Call for March 30, 2023

March 02, 2023

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences Announces Its Novel Nanosecond Pulsed Field Ablation System Will Be Highlighted at the 2023 AF Symposium

February 02, 2023

From Pulse Biosciences

Via Business Wire

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

December 06, 2022

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

December 02, 2022

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

November 25, 2022

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

November 24, 2022

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

November 23, 2022

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

November 22, 2022

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

November 15, 2022

Via Benzinga

Pulse Biosciences Reports Third Quarter 2022 Financial Results

November 10, 2022

From Pulse Biosciences, Inc.

Via Business Wire

Earnings Preview: Pulse Biosciences ↗

November 09, 2022

Pulse Biosciences (NASDAQ:PLSE) is set to give its latest quarterly earnings report on Thursday, 2022-11-10. Here's what investors need to know before the announcement. Analysts estimate that Pulse...

Via Benzinga

Pulse Biosciences Schedules Third Quarter 2022 Financial Results Conference Call for November 10, 2022

October 27, 2022

From Pulse Biosciences, Inc.

Via Business Wire

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

October 20, 2022

Gainers Nuwellis (NASDAQ:NUWE) stock rose 13.9% to $0.28 during Thursday's after-market session. The company's market cap stands at $8.9 million.

Via Benzinga

Pulse Biosciences Announces Positive Clinical Data on Nano-Pulse Stimulation Procedure for Low-Risk Basal Cell Carcinoma Lesions

October 06, 2022

From Pulse Biosciences, Inc.

Via Business Wire

Why AeroClean Technologies Shares Are Trading Higher By Around 38%, Here Are 58 Stocks Moving In Tuesday's Mid-Day Session ↗

October 04, 2022

Gainers Bit Brother Limited (NASDAQ: BTB) rose 229% to $0.3688 after declining around 14% on Monday.

Via Benzinga

Why F45 Training Shares Climbed 41%; Here Are 84 Biggest Movers From Friday ↗

October 03, 2022

Gainers FingerMotion, Inc. (NASDAQ: FNGR) gained 82.2% to close at $3.37.

Via Benzinga

Why Aridis Pharmaceuticals Shares Plunged Around 30%; Here Are 81 Biggest Movers From Yesterday ↗

September 27, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

September 26, 2022

Gainers

Via Benzinga

Pulse Biosciences Announces FDA 510(k) Clearance for the Treatment of Sebaceous Hyperplasia

September 26, 2022

From Pulse Biosciences, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For September 21, 2022 ↗

September 21, 2022

Upgrades For Berkshire Hathaway Inc (NYSE:BRK), Edward Jones upgraded the previous rating of Hold to Buy. Berkshire Hathaway earned $6312.49 in the second quarter, compared to $4399.91 in the year-ago...

Via Benzinga

Pulse Biosciences Announces Strategic Change of Focus in Support of Significant Additional Opportunities for medicinal related Nano-Pulse Stimulation

September 20, 2022

From Pulse Biosciences, Inc.

Via Business Wire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

August 24, 2022

Gainers Aridis Pharmaceuticals (NASDAQ:ARDS) shares moved upwards by 20.1% to $1.79 during Wednesday's after-market session. The market value of their outstanding shares is at $31.6 million.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

August 10, 2022

Via Benzinga

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.